DaVita Gross Profit 2010-2024 | DVA

DaVita annual/quarterly gross profit history and growth rate from 2010 to 2024. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
  • DaVita gross profit for the quarter ending March 31, 2024 was $0.992B, a 21.74% increase year-over-year.
  • DaVita gross profit for the twelve months ending March 31, 2024 was $3.998B, a 17.03% increase year-over-year.
  • DaVita annual gross profit for 2023 was $3.82B, a 12.35% increase from 2022.
  • DaVita annual gross profit for 2022 was $3.4B, a 6.75% decline from 2021.
  • DaVita annual gross profit for 2021 was $3.646B, a 2.37% increase from 2020.
DaVita Annual Gross Profit
(Millions of US $)
2023 $3,820
2022 $3,400
2021 $3,646
2020 $3,562
2019 $3,474
2018 $3,209
2017 $3,237
2016 $3,276
2015 $3,126
2014 $3,676
2013 $3,566
2012 $2,603
2011 $2,098
2010 $1,792
2009 $1,859
DaVita Quarterly Gross Profit
(Millions of US $)
2024-03-31 $992
2023-12-31 $1,007
2023-09-30 $1,054
2023-06-30 $945
2023-03-31 $815
2022-12-31 $828
2022-09-30 $863
2022-06-30 $910
2022-03-31 $799
2021-12-31 $884
2021-09-30 $930
2021-06-30 $951
2021-03-31 $882
2020-12-31 $848
2020-09-30 $952
2020-06-30 $895
2020-03-31 $866
2019-12-31 $898
2019-09-30 $913
2019-06-30 $885
2019-03-31 $778
2018-12-31 $794
2018-09-30 $784
2018-06-30 $818
2018-03-31 $814
2017-12-31 $839
2017-09-30 $813
2017-06-30 $805
2017-03-31 $779
2016-12-31 $198
2016-09-30 $1,033
2016-06-30 $1,047
2016-03-31 $999
2015-12-31 $188
2015-09-30 $1,025
2015-06-30 $989
2015-03-31 $925
2014-12-31 $962
2014-09-30 $925
2014-06-30 $926
2014-03-31 $863
2013-12-31 $935
2013-09-30 $904
2013-06-30 $857
2013-03-31 $869
2012-12-31 $770
2012-09-30 $619
2012-06-30 $614
2012-03-31 $600
2011-12-31 $584
2011-09-30 $568
2011-06-30 $498
2011-03-31 $448
2010-12-31 $334
2010-09-30 $505
2010-06-30 $476
2010-03-31 $477
2009-12-31 $472
2009-09-30 $478
2009-06-30 $467
2009-03-31 $442
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $12.360B $12.140B
DaVita Inc. is a leading provider of dialysis services in the U.S. to patients suffering from chronic kidney failure, also known as end-stage renal disease (ESRD). The company operates kidney dialysis centers and provides related medical services primarily in dialysis centers and in contracted hospitals across the U.S. Its services include outpatient dialysis services, hospital inpatient dialysis services and ancillary services such as ESRD laboratory services and disease management services. DaVita's Dialysis and related lab services business segment provides inpatient as well as outpatient dialysis services, routine laboratory testing for ESRD patients and management services to outpatient dialysis centers. The company's other ancillary services and strategic initiatives segment includes its international dialysis services, pharmacy services, infusion therapy services, disease management services, vascular access services, ESRD clinical research programs and physician services.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $16.911B 10.23
Quest Diagnostics (DGX) United States $16.016B 16.55
Encompass Health (EHC) United States $8.670B 22.19
Chemed (CHE) United States $8.544B 26.48
Elanco Animal Health (ELAN) United States $8.401B 21.80
Option Care Health (OPCH) United States $5.051B 19.12
RadNet (RDNT) United States $4.321B 89.99
Amedisys (AMED) United States $3.141B 22.25
LifeStance Health (LFST) United States $2.871B 0.00
Astrana Health (ASTH) United States $2.188B 29.59
Addus HomeCare (ADUS) United States $1.812B 25.92
U.S Physical Therapy (USPH) United States $1.588B 42.50
Pennant (PNTG) United States $0.695B 36.70
Aveanna Healthcare Holdings (AVAH) United States $0.560B 0.00
Atai Life Sciences (ATAI) Germany $0.290B 0.00
Daxor (DXR) United States $0.046B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.028B 0.00
ATI Physical Therapy (ATIP) United States $0.022B 0.00
Psychemedics (PMD) United States $0.015B 0.00
Ontrak (OTRK) United States $0.012B 0.00
Novo Integrated Sciences (NVOS) United States $0.008B 0.00
IMAC Holdings (BACK) United States $0.004B 0.00